将脂肪性肝病从非酒精性脂肪性肝病重新定义为代谢功能障碍相关脂肪性肝病提高了疾病认知度：墨西哥的经验。 - Suppr

Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience.

作者信息

Méndez-Sánchez Nahum, Díaz-Orozco Luis, Córdova-Gallardo Jacqueline

机构信息

Liver Research Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico; National Autonomous University of Mexico, Mexico City, Mexico.

出版信息

J Hepatol. 2021 Jul;75(1):221-222. doi: 10.1016/j.jhep.2021.04.021. Epub 2021 Apr 20.

DOI:10.1016/j.jhep.2021.04.021

PMID:33892008

Abstract

摘要

相似文献

Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience.将脂肪性肝病从非酒精性脂肪性肝病重新定义为代谢功能障碍相关脂肪性肝病提高了疾病认知度：墨西哥的经验。

J Hepatol. 2021 Jul;75(1):221-222. doi: 10.1016/j.jhep.2021.04.021. Epub 2021 Apr 20.

Hepatologists' Awareness and Knowledge of NAFLD and the Familiarity with Renaming NAFLD to MAFLD.肝科医生对非酒精性脂肪性肝病（NAFLD）的认识和了解，以及对将其更名为 MAFLD 的熟悉程度。

Endocr Metab Immune Disord Drug Targets. 2024;24(12):1445-1453. doi: 10.2174/1871530323666221028154159.

NAFLD, MAFLD and DAFLD.非酒精性脂肪性肝病、代谢相关脂肪性肝病和糖尿病性脂肪性肝病。

Dig Liver Dis. 2020 Dec;52(12):1519-1520. doi: 10.1016/j.dld.2020.09.013. Epub 2020 Oct 2.

The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease.拉丁美洲肝脏研究学会（ALEH）关于重新定义脂肪肝疾病的立场声明。

Lancet Gastroenterol Hepatol. 2021 Jan;6(1):65-72. doi: 10.1016/S2468-1253(20)30340-X. Epub 2020 Nov 9.

Redefining fatty liver disease: an international patient perspective.重新定义脂肪肝疾病：国际患者视角。

Lancet Gastroenterol Hepatol. 2021 Jan;6(1):73-79. doi: 10.1016/S2468-1253(20)30294-6. Epub 2020 Oct 5.

Comparison of MAFLD and NAFLD diagnostic criteria in real world.现实世界中MAFLD与NAFLD诊断标准的比较。

Liver Int. 2020 Sep;40(9):2082-2089. doi: 10.1111/liv.14548. Epub 2020 Jul 26.

Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio Study.从非酒精性脂肪性肝病到代谢相关性脂肪性肝病的转变中的未决问题：Plinio 研究的经验。

Int J Environ Res Public Health. 2021 Aug 26;18(17):8993. doi: 10.3390/ijerph18178993.

A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe.一项关于欧洲对非酒精性脂肪性肝病公共卫生应对措施的横断面研究。

J Hepatol. 2020 Jan;72(1):14-24. doi: 10.1016/j.jhep.2019.08.027. Epub 2019 Sep 10.

The sub-Saharan Africa position statement on the redefinition of fatty liver disease: From NAFLD to MAFLD.撒哈拉以南非洲关于脂肪肝疾病重新定义的立场声明：从非酒精性脂肪性肝病到代谢相关脂肪性肝病

J Hepatol. 2021 May;74(5):1256-1258. doi: 10.1016/j.jhep.2021.01.015. Epub 2021 Jan 20.

MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.MAFLD：代谢相关脂肪性肝病的共识驱动命名建议。

Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.

引用本文的文献

Two years on, a perspective on MAFLD.两年后，对代谢功能障碍相关脂肪性肝病的展望。

eGastroenterology. 2023 Sep 11;1(2):e100019. doi: 10.1136/egastro-2023-100019. eCollection 2023 Sep.

Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma.代谢功能障碍相关脂肪性肝病的自然史：从代谢综合征到肝细胞癌

Medicina (Kaunas). 2025 Jan 7;61(1):88. doi: 10.3390/medicina61010088.

Impact of metabolic-associated fatty liver disease on the cholesterol efflux capacity of high-density lipoproteins in adolescents with type 2 diabetes.代谢相关脂肪性肝病对2型糖尿病青少年高密度脂蛋白胆固醇流出能力的影响。

Front Pediatr. 2024 Dec 24;12:1462406. doi: 10.3389/fped.2024.1462406. eCollection 2024.

An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease.关于代谢功能障碍相关脂肪性肝病与慢性肾脏病风险的国际德尔菲共识声明

Hepatobiliary Surg Nutr. 2023 Jun 1;12(3):386-403. doi: 10.21037/hbsn-22-421. Epub 2023 Feb 23.

The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease.饮酒与代谢相关脂肪性肝病（MAFLD）对进展性脂肪性肝病的双向影响。

Ther Adv Endocrinol Metab. 2023 Jun 5;14:20420188231178370. doi: 10.1177/20420188231178370. eCollection 2023.

Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate.代谢相关脂肪性肝病：新命名及引发热议的处理方法

World J Hepatol. 2023 Feb 27;15(2):123-128. doi: 10.4254/wjh.v15.i2.123.

NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care.NAFLD、MAFLD 及其他：一个或多个缩写词，以更好地理解和患者护理。

Intern Emerg Med. 2023 Jun;18(4):993-1006. doi: 10.1007/s11739-023-03203-0. Epub 2023 Feb 17.

Cirrhosis etiology trends in developing countries: Transition from infectious to metabolic conditions. Report from a multicentric cohort in central Mexico.发展中国家肝硬化病因的趋势：从感染性疾病向代谢性疾病的转变。来自墨西哥中部一个多中心队列的报告。

Lancet Reg Health Am. 2021 Dec 21;7:100151. doi: 10.1016/j.lana.2021.100151. eCollection 2022 Mar.

MAFLD: what 2 years of the redefinition of fatty liver disease has taught us.代谢相关脂肪性肝病：脂肪肝疾病重新定义的两年给我们带来的启示

Ther Adv Endocrinol Metab. 2022 Nov 22;13:20420188221139101. doi: 10.1177/20420188221139101. eCollection 2022.

The NAFLD-MAFLD debate through the lens of the Arab world.从阿拉伯世界的视角看非酒精性脂肪性肝病与代谢相关性脂肪性肝病之争。

Saudi J Gastroenterol. 2022 Nov-Dec;28(6):413-416. doi: 10.4103/sjg.sjg_314_22.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献